Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease

BACKGROUND: According to new diagnostic guidelines for Alzheimer’s disease (AD), biomarkers enable estimation of the individual likelihood of underlying AD pathophysiology and the associated risk of progression to AD dementia for patients with mild cognitive impairment (MCI). Nonetheless, how confli...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Alzheimers Res Ther
Hlavní autoři: Alexopoulos, Panagiotis, Werle, Lukas, Roesler, Jennifer, Thierjung, Nathalie, Gleixner, Lena Sophie, Yakushev, Igor, Laskaris, Nikolaos, Wagenpfeil, Stefan, Gourzis, Philippos, Kurz, Alexander, Perneczky, Robert
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2016
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5146856/
https://ncbi.nlm.nih.gov/pubmed/27931251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-016-0220-z
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky